Celldex Therapeutics (CLDX) Tops Q2 Loss Views by 2c/Share

August 10, 2012 7:01 AM EDT Send to a Friend
Celldex Therapeutics (NASDAQ: CLDX) reported Q2 EPS of ($0.23), $0.02 better than the analyst estimate of ($0.25).

For earnings history and earnings-related data on Celldex Therapeutics (CLDX) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings

Add Your Comment